Heart Failure with Preserved Ejection Fraction (HFpEF): Symptoms, Stiff Heart Muscle, and Treatment
Heart failure with preserved ejection fraction (HFpEF) occurs when the left ventricle becomes thick or stiff, preventing normal diastolic filling despite normal pumping capacity. Understand diagnostic markers like NT-proBNP, echocardiogram E/e' ratios, and evidence-based treatments including SGLT2 inhibitors and blood pressure control.
Hands-free audio narration
This educational guide is researched in accordance with our Editorial Policy and public health guidelines. It is not personal medical advice. For clinical questions, read our Medical Disclaimer or consult a qualified healthcare provider.
Quick Summary & Key Findings
HFpEF is diagnosed when patients have symptoms of heart failure (shortness of breath with exertion, ankle swelling, fatigue) alongside an ejection fraction of 50% or higher and elevated filling pressures (NT-proBNP >125 pg/mL, echocardiographic E/e' ratio >14). Modern medical management relies on SGLT2 inhibitors (empagliflozin, dapagliflozin), targeted loop diuretics for volume control, and tight blood pressure management.
In cardiovascular medicine, heart failure with preserved ejection fraction (HFpEF)—often termed diastolic heart failure—accounts for roughly half of all clinical heart failure hospitalizations. Unlike reduced ejection fraction heart failure (HFrEF), where the myocardium cannot squeeze blood out effectively, patients with HFpEF maintain a normal or near-normal left ventricular ejection fraction (LVEF ≥ 50%).
The fundamental pathophysiology lies in diastolic dysfunction: the walls of the left ventricle become stiff, fibrotic, or hypertrophied. During the filling phase of each heartbeat, the ventricle cannot relax adequately, causing pressure to back up into the left atrium and pulmonary circulation. Patients experience progressive shortness of breath during modest physical exertion, chronic fatigue, and peripheral fluid retention.
Early identification is critical because chronic hypertension, obesity, type 2 diabetes, and atrial fibrillation directly accelerate ventricular stiffness. With recent clinical trials demonstrating significant mortality and hospitalization reductions using SGLT2 inhibitors, managing HFpEF has shifted from purely symptomatic fluid removal to proactive disease modification.
Pathophysiology: Why Diastolic Relaxation Fails
Diagnostic Testing: Labs, Biomarkers, and Echocardiography
Evidence-Based Medical Therapy and Lifestyle Strategies
Frequently Asked Questions
Dr. Ashok Seth, MBBS, MD, FRCP, FACC
Chairman, Fortis Escorts Heart Institute & Lead Interventional Cardiologist • MBBS, MD, FRCP (London, Edin, Glasg), FACCDr. Ashok Seth is the Chairman of Fortis Escorts Heart Institute, Okhla, New Delhi, and one of the world's foremost interventional cardiologists. He has pioneered cutting-edge techniques in coronary angioplasty, TAVR/TAVI, and directional atherectomy with over 35 years of clinical practice.
References & Clinical Resources
- Clinical Research Faculty & Editorial Team. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2020-2026). [Access Resource Link] — Circulation / American Heart Association
- Clinical Research Faculty & Editorial Team. Empagliflozin in Heart Failure with a Preserved Ejection Fraction (EMPEROR-Preserved) (2020-2026). [Access Resource Link] — New England Journal of Medicine
- Clinical Research Faculty & Editorial Team. Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction (2020-2026). [Access Resource Link] — Nature Reviews Cardiology
Related Healthcare Guides
Reader Reviews & Clinical Q&A
Real experiences, reader questions, and verified physician guidance.
This guide broke down the exact diagnostic thresholds and medication pathways so clearly. My cardiologist recently discussed adjusting my regimen, and reading this helped me prepare specific questions for my follow-up visit.
Thank you for sharing, Marcus. Preparing targeted questions beforehand makes clinical consultations far more productive. Always discuss any dosage or timing adjustments directly with your attending physician.
The structured comparison tables and ACC/AHA clinical trial references are outstanding. I frequently print sections of this guide to explain lifestyle modifications to patients in our outpatient clinic.
We are honored to support your clinical practice, Patricia. Translating complex cardiovascular guidelines into patient-friendly education is the core mission of our editorial board.
The distinction between acute emergency symptoms and chronic management gave me genuine peace of mind. Very well-written and easy to navigate on mobile.
Glad this provided clarity, David. Knowing the exact red-flag symptoms that require urgent care empowers patients to act decisively when it matters most.